Evidence map›Paper›PMID 18239455›Full record

ReviewCell cycle (Georgetown, Tex.)2008

Leukemia and hematopoietic stem cells: balancing proliferation and quiescence.

Craig D Jude, Justin J Gaudet, Nancy A Speck, Patricia Ernst

Abstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. The Ah receptor in stem cell cycling, regulation, and quiescence.Annals of the New York Academy of Sciences · 2014
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Craig D JudeDepartment of Genetics, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.
Justin J Gaudet
Nancy A Speck
Patricia Ernst

Funding

MLL Function in the Maintenance of the Blood Forming SystemR01HL090036 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ERNST, PATRICIA · 2007 to 2015
$3.8M
Structural Biology of AML (CBFA2) and AML1-ETOR01CA108056 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BUSHWELLER, JOHN HACKETT · 2004 to 2014
$3.5M
Runx1 as a Marker for Stem SellsR01AI051427 · NIAID · DARTMOUTH COLLEGE · PI ERNST, PATRICIA A · 2003 to 2007
$2.0M
AUTOIMMUNITY &CONNECTIVE TISSUE BIOLOGY TRAININGT32AR007576 · NIAMS · DARTMOUTH COLLEGE · PI RIGBY, WILLIAM FREDERICK CARSON · 1994 to 2008
$1.7M
MII Regulation of HematopoiesisK01DK067119 · NIDDK · DARTMOUTH COLLEGE · PI ERNST, PATRICIA · 2004 to 2008
$646k
NCI NIH HHS R01 CA108056NHLBI NIH HHS R01 HL090036NIAID NIH HHS AI051427NIAID NIH HHS R01 AI051427NIAMS NIH HHS T32 AR007576NIAMS NIH HHS T32 AR07576NIDDK NIH HHS DK067119NIDDK NIH HHS K01 DK067119
6 · The paper itself

Abstract

Chromosomal translocations that disrupt transcriptional regulators are frequently involved in the etiology of leukemia. To gain an understanding of the normal and pathologic roles of these transcriptional regulators, both gain- and loss-of-function mutations have been examined in the context of steady-state hematopoiesis. These studies have identified a remarkable number of genes whose loss-of-function phenotype includes a perturbation of hematopoietic stem cell (HSC) proliferation. As more of these models are generated and analyzed using commonly available tools, the regulatory pathways that control HSC quiescence and proliferation are becoming clearer. An emerging theme is that leukemia-associated transcriptional regulators coordinate the balance of proliferation and quiescence within the HSC pool by modulating the number and frequency of cells transiting the cell cycle. Uncoupling proliferation from differentiation by the aberrant generation of chimeric oncogenes that retain some, but not all of the attributes of the original transcription factor is likely to be an important step during leukemogenesis.

Indexed as

AnimalsCell CycleCell ProliferationHematopoietic Stem CellsHomeostasisHumansLeukemiaMutation

Identifiers

PMID18239455
PMCPMC2892629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.